Aepodia is a CRO dedicated to Early Clinical Development and Clinical Pharmacology studies (Scientific Consultancy and Operational and Quality support). Thanks to their pharmacological, scientific and study design background, our experienced staff prepares and executes well balanced and optimized compound early phase development plan from First-In-Man until Proof of Concept, including added value biomarker strategy. Aepodia has competitive advantages to meet aggressive timelines for Biopharmaceutical Package (including special population, bioequivalence and Qtc) studies. Therapeutic Areas of expertise: • CNS • Metabolic disease • Endocrine • Cardiovascular • Inflammatory • Urology, impotency • Respiratory • Oncology (Operational) For full services or single activities, you can rely on Aepodia to prepare and manage your clinical Plan and Phase 1/2a Clinical Studies, including investigator site and Phase 1 unit selection, Project Management, study feasibility, study management and monitoring. Aepodia assists also clients in the nutrition industry to prepare and conduct human trials to support health claims. Aepodia understands the environment and needs of the Nutrition Industry. Our expertise in pharmaceutical clinical trials is directly applicable to nutraceutical products. Aepodia is a human size company able to meet your individual outsourcing strategy working to the highest quality Requirements and Ethics.